Levetiracetam: the first SV2A ligand for the treatment of epilepsy
Year: 2007
Type: article
Source: Expert Opinion on Drug Discovery
Authors: Henrik Klitgaard, Peter Verdru
Institution: UCB Pharma (Belgium)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2025467584
